Profound Medical (PROF) Peer Comparison

$6.88

$-0.08 (-1.09%)

As on 28-Aug-2026 13:33EDT

Market cap

$248 Mln

Revenue (TTM)

$19 Mln

P/E Ratio

--

P/B Ratio

4.9

Div. Yield

0 %

Edit

	Profound Medical (PROF)	Bausch + Lomb Corp (BLCO)	Viemed Healthcare (VMD)
Market cap ($ Mln)	248	6,233	337
Revenue ($ Mln)	19	5,319	302
Net Profit ($ Mln)	-32.65	-171.00	14.50
Net Margin (%)	-171.72	-3.21	4.81
RoE (%)	-46.38	-2.79	9.78
Price to Earnings	--	--	23.92
Price-To-Book	4.88	0.98	2.26

Cashflow
Ratios

Cashflow ($ Mln)

	Profound Medical (PROF)	Bausch + Lomb Corp (BLCO)	Viemed Healthcare (VMD)
Cash From Operating Activities	-38.88	283.00	51.92
Cash Flow from Investing Activities	-0.25	-455.00	-50.17
Cash from Financing Activities	41.86	225.00	-5.79
Net Cash Inflow / Outflow	--	--	--

Ratios

Profitability Ratios

	Profound Medical (PROF)	Bausch + Lomb Corp (BLCO)	Viemed Healthcare (VMD)
ROCE (%)	-53.15	-3.10	10.10
ROE (%)	-46.38	-2.79	9.78
ROA (%)	-51.46	-1.09	6.12
EBIT Margin (%)	-177.13	6.22	7.75
Net Margin (%)	-171.72	-3.21	4.81
Cash Profit Margin (%)	0.00	0.00	0.00

Growth Ratios

	Profound Medical (PROF)	Bausch + Lomb Corp (BLCO)	Viemed Healthcare (VMD)
Revenue Growth (%)	62.18	8.75	25.21
EBIT Growth (%)	22.64	967.74	31.75
Net Profit Growth (%)	20.60	37.36	3.73
EPS Growth (%)	32.81	37.71	5.67
Book Value Growth (%)	4.83	-1.94	2.97

Valuation Ratios

	Profound Medical (PROF)	Bausch + Lomb Corp (BLCO)	Viemed Healthcare (VMD)
Price / Earnings	-5.58	-16.81	19.98
Price / Book Value	2.66	0.94	2.11
Dividend Yield (%)	--	--	--
EV/EBITDA	-4.02	20.64	5.83
Market Cap ($ Cr)	--	--	--

Solvency Ratios

	Profound Medical (PROF)	Bausch + Lomb Corp (BLCO)	Viemed Healthcare (VMD)
Debt to Equity	0.00	0.80	0.04
Short term debt to equity ratio	0.09	0.01	0.01
Current Ratio	6.45	1.55	1.13
Quick Ratio	5.31	1.02	1.02
Interest Coverage	--	0.84	15.88

Operating Efficiency Ratios

	Profound Medical (PROF)	Bausch + Lomb Corp (BLCO)	Viemed Healthcare (VMD)
Debtors to sales (%)	50.57	21.81	10.69
Asset Turnover	0.30	0.34	1.27
Receivable days	188.50	80.45	34.12
Inventory Days	651.71	159.20	14.90
Payable days	131.90	61.48	34.46
Cash Conversion Cycle	708.30	178.17	14.56

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Annual
Quarterly